Results 91 to 100 of about 110,071 (192)

mRNA vaccines: A matter of delivery [PDF]

open access: yesEClinicalMedicine, 2021
Cao, Yuhong, Gao, George F.
openaire   +3 more sources

Immunogenicity of HIV-1 Env mRNA and Env-Gag VLP mRNA Vaccines in Mice

open access: yes
Background: The development of a protective vaccine is critical for conclusively ending the human immunodeficiency virus (HIV) epidemic. Methods: We constructed nucleotide-modified mRNA vaccines expressing HIV-1 Env and Gag proteins.
Yanzhe Hao   +5 more
core   +1 more source

Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy

open access: yesFrontiers in Immunology
Cancer continues to pose an alarming threat to global health, necessitating the need for the development of efficient therapeutic solutions despite massive advances in the treatment. mRNA cancer vaccines have emerged as a hopeful avenue, propelled by the
Umm E. Laila, Wang An, Zhi-Xiang Xu
doaj   +1 more source

A Bivalent mRNA Vaccine Efficiently Prevents Gammaherpesvirus Latent Infection

open access: yes
Background: It is still challenging to develop effective vaccines against tumorigenic human gammaherpesviruses such as Epstein–Barr virus (EBV). A major obstacle is the lack of a small animal model that reproduces the natural infection course of human ...
Haikun Wang   +9 more
core   +1 more source

Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2

open access: yesnpj Vaccines
The COVID-19 pandemic spurred mRNA vaccine innovation, but new SARS-CoV-2 variants highlight the need for vaccines with improved potency and durability.
Jason P. Laliberte   +28 more
doaj   +1 more source

The Recent Research Progress of the Tumor mRNA Vaccine

open access: yes
Tumors have long posed a significant threat to human life and health, and the messenger ribonucleic acid (mRNA) vaccine is seen as an attractive approach for cancer immunotherapy due to its developmental simplicity, rapid manufacture, and increased ...
Miying Li   +5 more
core   +1 more source

mRNA vaccines as cancer therapies

open access: yesChinese Medical Journal
Abstract Cancer remains a major global health challenge, with conventional treatments like chemotherapy and radiotherapy often hindered by significant side effects, lack of specificity, and limited efficacy in advanced cases.
Shaoxiong Huang   +4 more
openaire   +3 more sources

Freeze-Drying of mRNA-LNPs Vaccines: A Review

open access: yes
The instability of mRNA vaccines presents significant challenges for their storage, transportation, and large-scale distribution, particularly in resource-limited countries.
Ayyappasamy Sudalaiyadum Perumal   +3 more
core   +1 more source

Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines

open access: yes
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the waning of immunity over time has necessitated the use of booster doses of original coronavirus disease 2019 (COVID-19) vaccines.
Ivan Aloysius   +3 more
core   +1 more source

Codon pair bias and viral vaccine design

open access: yes, 2015
The authors acknowledge the long term support of the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.Live attenuated vaccines (LAVs) have prevented morbidity and mortality against a number of important viral diseases (such ...
Tulloch, Fiona Ashley   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy